Tun Kiat Ko, PhD1*, Xin Xuan Sheila Soh1*, Willie Yu, PhD1*, Peter S. Winter2*, Thushangi Pathiraja, PhD3*, Asif Javed, PhD4*, Simeen Malik, PhD1*, Joanna H.J. Tan3*, Charles Chuah, MD, PhD1,5, Naoto Takahashi, M.D., Ph.D.6, Ravi Bhatia, MD7, Wee Joo Chng, MD, PhD8,9, Peter Valent, MD10,11, Sabine Cerny-Reiterer, DVM10,11*, King Pan Ng, PhD8*, Chandana Tennakoon, PhD4*, Qiangze Hoi4*, Peiyong Guan4*, Audrey S.M. Teo3*, Wah Heng Lee, PhD4*, Patrick Tan, MD, PhD8,12,13*, Win Kin Sung, PhD4*, Pauline Ng, PhD4*, Axel Hillmer, PhD3*, Kris C. Wood, PhD2*, Steve Rozen, PhD1* and S. Tiong Ong, MD1,14
1Cancer & Stem Cell Biology Signature Research Program, Duke-NUS Graduate Medical School, Singapore, Singapore
2Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC
3Cancer Therapeutics & Stratified Oncology, Genome Institute of Singapore, Singapore, Singapore
4Computational & Systems Biology, Genome Institute of Singapore, Singapore, Singapore
5Singapore General Hospital, Singapore, Singapore
6Department of Hematology, Nephrology and Rheumatology, Akita University, Akita, Japan
7Department of Hematopoietic Stem cell and Leukemia Research, City of Hope, Duarte, CA
8Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore
9Department of Haematology-Oncology, National University Cancer Institute of Singapore, Singapore, Singapore
10Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
11Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, Austria
12Program in Cancer and Stem Cell Biology, Duke-NUS Graduate Medical School, Singapore, Singapore
13Genome Institute of Singapore, A*STAR, Singapore, Singapore
14Department of Haematology, Singapore General Hospital, Singapore, Singapore